<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03409770</url>
  </required_header>
  <id_info>
    <org_study_id>241031</org_study_id>
    <nct_id>NCT03409770</nct_id>
  </id_info>
  <brief_title>Cooling in Mild Encephalopathy</brief_title>
  <acronym>COMET</acronym>
  <official_title>Optimising the Duration of Cooling Therapy in Mild Neonatal Encephalopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thayyil, Sudhin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thayyil, Sudhin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase II randomised control trial of whole body cooling in mild neonatal encephalopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND Approximately one million full term babies die and an equivalent number become
      disabled for life every year as a result of birth asphyxia related brain injury. Although
      cooling the body to 33.5°C for 72 hours benefits babies who have severe forms of brain
      injury, most babies have milder forms of brain injury (i.e. mild encephalopathy). It is not
      known whether such cooling is effective in mild encephalopathy, and if so, what the optimal
      duration of cooling should be. Our previous data suggest that an early measurement of the
      brain concentration of N-acetylaspartate (NAA, a chemical present in neurons) accurately
      predicts adverse developmental outcomes at two years of age, and correlates with their
      cognitive skills scores at this age.

      AIMS

        1. To identify the optimal duration of cooling therapy in mild encephalopathy that results
           in the highest likelihood of increased thalamic N-acetyl aspartate concentration at 1
           week of age?

        2. To examine if cooling therapy for this optimal duration increase thalamic N-acetyl
           aspartate concentration at 1 week of age, when compared with usual care (normothermia)?

      METHODS A total of 220 babies with mild neonatal encephalopathy will be recruited from
      several large hospitals in the UK, USA and Canada, and will be randomised to usual care
      (normothermia) or whole body cooling for one of five durations: 24h, 36h, 48h, 60h or 72h.
      The thalamic concentration of N-acetylaspartate, [NAA], will be measured using 3 Tesla
      magnetic resonance (MR) spectroscopy performed between 4 and 14 days after birth.

      DATA ANALYSIS AND OUTCOME MEASURES The optimal cooling duration will be first identified by
      estimating the duration-response curve. Briefly, thalamic [NAA] will be plotted against
      cooling duration and a flexible model used to describe their relationship. The optimal
      duration will then be selected from this duration-response curve.

      The prognoses of babies allocated to the group with the optimal cooling duration will then be
      compared with those of normothermic controls, by assessing the difference in mean thalamic
      [NAA].
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Therapeutic hypothermia (33 to 34 C) for 5 different durations (24, 36, 48, 60 and 72 h) and usual care (normothermia)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>MR spectroscopy analysis will be masked to the allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Thalamic N-acetyl aspartate level</measure>
    <time_frame>4 to 14 days after birth</time_frame>
    <description>Proton MR spectroscopy thalamic N-acetyl aspartate level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain injury on conventional MR imaging</measure>
    <time_frame>4 to 14 days after birth</time_frame>
    <description>Cortical, white matter or deep nuclei injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Upto 30 days after birth</time_frame>
    <description>Duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombocytopenia</measure>
    <time_frame>Upto 30 days after birth</time_frame>
    <description>Low platelet levels requiring platelet transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Culture positive sepsis</measure>
    <time_frame>Upto 30 days after birth</time_frame>
    <description>Blood or CSF positive sepsis</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Neonatal Encephalopathy</condition>
  <condition>Hypothermia Neonatal</condition>
  <condition>Magnetic Resonance Spectroscopy</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care (normothermia) arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic hypothermia - 24 h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole body cooling (33 to 34 C) for 24 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic hypothermia - 36 h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole body cooling (33 to 34 C) for 36 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic hypothermia - 48 h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole body cooling (33 to 34 C) for 48 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic hypothermia - 60 h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole body cooling (33 to 34 C) for 60 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic hypothermia - 72 h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Whole body cooling (33 to 34 C) for 72 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic hypothermia</intervention_name>
    <description>Whole body cooling using a servo controlled device</description>
    <arm_group_label>Therapeutic hypothermia - 24 h</arm_group_label>
    <arm_group_label>Therapeutic hypothermia - 36 h</arm_group_label>
    <arm_group_label>Therapeutic hypothermia - 48 h</arm_group_label>
    <arm_group_label>Therapeutic hypothermia - 60 h</arm_group_label>
    <arm_group_label>Therapeutic hypothermia - 72 h</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All of the following four criteria should be met:

          1. Age less than six hours.

          2. Evidence of acute perinatal asphyxia (metabolic acidosis (pH&lt;7.15 and/or BE &gt;-12) in
             cord and/or blood gas within 1h of birth and/or an acute obstetric event e.g. cord
             prolapse, abruption, shoulder dystocia)

          3. Need for continued resuscitation or ventilation at 10 minutes and a 10 min Apgar score
             &lt;6

          4. Evidence of mild NE on an NICHD neurological examination performed between 1 and 6h of
             birth.

        Exclusion Criteria:

          1. Babies without encephalopathy

          2. Babies with moderate or severe encephalopathy who meet the current NICE/AAP guidelines
             for cooling therapy.

          3. Babies with seizures (clinical and/or aEEG/EEG)

          4. Babies with life threatening congenital malformations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sudhin Thayyil, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pete Lally</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pete Lally</last_name>
    <phone>0044203 313 2473</phone>
    <email>p.lally@imperial.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pete Lally</last_name>
    <email>p.lally@imperial.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medway NHS Foundation Trust</name>
      <address>
        <city>Gillingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ujwal Kariholu, MRCPCH</last_name>
      <phone>00442033132473</phone>
      <email>ujwalkariholu@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Newcastle Upon Tyne NHS Foundation Trust</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Prempunpong C, Chalak LF, Garfinkle J, Shah B, Kalra V, Rollins N, Boyle R, Nguyen KA, Mir I, Pappas A, Montaldo P, Thayyil S, Sánchez PJ, Shankaran S, Laptook AR, Sant'Anna G. Prospective research on infants with mild encephalopathy: the PRIME study. J Perinatol. 2018 Jan;38(1):80-85. doi: 10.1038/jp.2017.164. Epub 2017 Nov 2.</citation>
    <PMID>29095433</PMID>
  </reference>
  <reference>
    <citation>Oliveira V, Singhvi DP, Montaldo P, Lally PJ, Mendoza J, Manerkar S, Shankaran S, Thayyil S. Therapeutic hypothermia in mild neonatal encephalopathy: a national survey of practice in the UK. Arch Dis Child Fetal Neonatal Ed. 2017 Sep 23. pii: fetalneonatal-2017-313320. doi: 10.1136/archdischild-2017-313320. [Epub ahead of print]</citation>
    <PMID>28942433</PMID>
  </reference>
  <reference>
    <citation>Lally PJ, Montaldo P, Oliveira V, Swamy RS, Soe A, Shankaran S, Thayyil S. Residual brain injury after early discontinuation of cooling therapy in mild neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2017 Sep 21. pii: fetalneonatal-2017-313321. doi: 10.1136/archdischild-2017-313321. [Epub ahead of print]</citation>
    <PMID>28935718</PMID>
  </reference>
  <reference>
    <citation>Lally PJ, Pauliah S, Montaldo P, Chaban B, Oliveira V, Bainbridge A, Soe A, Pattnayak S, Clarke P, Satodia P, Harigopal S, Abernethy LJ, Turner MA, Huertas-Ceballos A, Shankaran S, Thayyil S. Magnetic Resonance Biomarkers in Neonatal Encephalopathy (MARBLE): a prospective multicountry study. BMJ Open. 2015 Sep 30;5(9):e008912. doi: 10.1136/bmjopen-2015-008912.</citation>
    <PMID>26423856</PMID>
  </reference>
  <reference>
    <citation>Robertson NJ, Thayyil S, Cady EB, Raivich G. Magnetic resonance spectroscopy biomarkers in term perinatal asphyxial encephalopathy: from neuropathological correlates to future clinical applications. Curr Pediatr Rev. 2014;10(1):37-47. Review.</citation>
    <PMID>25055862</PMID>
  </reference>
  <reference>
    <citation>Lally PJ, Price DL, Pauliah SS, Bainbridge A, Kurien J, Sivasamy N, Cowan FM, Balraj G, Ayer M, Satheesan K, Ceebi S, Wade A, Swamy R, Padinjattel S, Hutchon B, Vijayakumar M, Nair M, Padinharath K, Zhang H, Cady EB, Shankaran S, Thayyil S. Neonatal encephalopathic cerebral injury in South India assessed by perinatal magnetic resonance biomarkers and early childhood neurodevelopmental outcome. PLoS One. 2014 Feb 5;9(2):e87874. doi: 10.1371/journal.pone.0087874. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92526.</citation>
    <PMID>24505327</PMID>
  </reference>
  <reference>
    <citation>Thayyil S, Chandrasekaran M, Taylor A, Bainbridge A, Cady EB, Chong WK, Murad S, Omar RZ, Robertson NJ. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics. 2010 Feb;125(2):e382-95. doi: 10.1542/peds.2009-1046. Epub 2010 Jan 18.</citation>
    <PMID>20083516</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2018</study_first_submitted>
  <study_first_submitted_qc>January 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2018</study_first_posted>
  <last_update_submitted>January 17, 2018</last_update_submitted>
  <last_update_submitted_qc>January 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

